The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress
Fig 5
Diabetes-induced decrease in occludin was inhibited by treatment with ATWLPPR.
*P < 0.05, versus the Normal group; #P < 0.05, versus the D+saline group. D, Diabetic.